|
|
SPOT ON
|
|
Bevacizumab (AVASTIN) against cancer … with money-back guarantee for hospitals
|
|
|
NEW ON THE MARKET
|
|
Xylometazoline + ipratropium bromide (OTRIVEN DUO) against rhinitis
Attention-deficit hyperactivity disorder: methylphenidate for adults?
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Reducing lipoprotein(a) with nicotinic acid?
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Early benefit assessment of ticagrelor (BRILIQUE) by IQWiG
"Individual health services" (IGeL) reviewed … screening for glaucoma, ovarian and endometrial cancer without proven benefit
|
|
|
IN BRIEF
|
|
Cave: hyperkalemia with spironolactone plus trimethoprim
Marketing via "market research"
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Breast cancer with glatiramer acetate (COPAXONE)
|
|
|
SIDE EFFECTS
|
|
Dronedarone (MULTAQ): restriction of indication and warnings instead of market withdrawal
|
|
|
e a-t IN THE INTERNET
|
|
Cardiovascular risks of varenicline (CHAMPIX)
|
|